Aldeyra Therapeutics, Inc. (ALDX) › EPS (Diluted)Aldeyra Therapeutics, Inc. (ALDX) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2013: $-17.612014: $-3.092015: $-1.402021: $-1.072022: $-1.062023: $-0.642024: $-0.942025: $-0.56$-0.562013EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.56+40.4%2024$-0.94-46.9%2023$-0.64+39.6%2022$-1.06+0.9%2021$-1.07—2015$-1.40+54.7%2014$-3.09+82.5%2013$-17.61—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share